News

Deal Announcements

Arsenal Medical Secures $3 Million Venture Capital Debt

Friday, October 5, 2012 5:54:00 AM PDT | VentureDeal
   Watertown, Massachusetts  --  Biotechnology company Arsenal Medical has received $3 million in new venture capital debt investment, according to an SEC regulatory filing.

Arsenal is developing a nano-fiber drug delivery system for a wide range of local drug delivery applications.

Investors in the financing were not disclosed, nor was how the company intends to use proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1